Abstract
Long-Term Follow-up of the Efficacy and Safety of Ponatinib in Philadelphia Chromosome-Positive Leukemia Patients with the T315I Mutation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have